Equity Overview
Price & Market Data
Price: $1.35
Daily Change: +$0.03 / 2.22%
Daily Range: $1.25 - $1.35
Market Cap: $2,667,410
Daily Volume: 56,136
Performance Metrics
1 Week: -7.34%
1 Month: -3.99%
3 Months: -37.50%
6 Months: -58.72%
1 Year: -83.08%
YTD: -60.51%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.